In this issue:
- Urgency vs. triage prioritisation appropriateness of NZ dermatology referrals
- Adjuvant cemiplimab for high-risk cutaneous SCC
- Narrative vs. structured pathology reporting for cutaneous SCC
- Anti-PD-1 therapy in unresectable desmoplastic melanoma
- Characterisation of different clinical presentations of MCC
- Inherited mitochondrial genetics for predicting ICI efficacy in melanoma
- SPOTS: skin cancer prevention educational programme for adolescents
- Pembrolizumab-related toxicities in advanced melanoma
- Melanoma in pregnancy
Please login below to download this issue (PDF)